Chengdu
300841.SZChengdu Kanghua Biological Products Co., Ltd. Price (300841.SZ)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
133,747,266
(0.1703)%Revenue and Profitability
| Year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 71,069,286 | 92,916,354 | 261,930,180 | 559,467,534 | 554,636,645 | 1,038,636,032 | 1,292,447,990 | 1,446,724,761 | 1,577,395,401 |
| Net Income | 11,701,687 | 6,657,929 | 74,457,944 | 154,139,677 | 186,686,665 | 408,046,268 | 829,477,810 | 598,066,216 | 509,215,964 |
| FCF USD | 3,434,676 | 787,833 | 85,425,059 | 22,774,261 | 158,694,546 | 233,895,931 | -184,613,674 | -224,235,627 | 416,708,643 |
| OCF USD | 6,505,200 | 2,643,300 | 89,956,333 | 57,354,823 | 182,729,747 | 369,564,379 | 130,325,659 | 194,990,553 | 573,983,329 |
Financial Health - DEBT
| Year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.00 |
| D/E | -0.01 | 0.00 | 0.04 | 0.05 | 0.02 | 0.00 | 0.00 | 0.04 | 0.05 |
| CA/CL | 0.32 | 0.42 | 2.45 | 3.36 | 5.11 | 10.45 | 5.73 | 3.51 | 3.90 |
| TA/TL | 0.62 | 0.68 | 3.18 | 4.11 | 6.02 | 12.40 | 8.68 | 5.84 | 6.05 |
| Total Debt | 659,700 | 416,400 | 7,500,000 | 19,000,000 | 10,000,000 | 2,340,034 | 900,522 | 126,351,135 | 190,913,849 |
Management Performance
| Year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|
| ROIC | -10.30% | -6.57% | 37.87% | 39.74% | 31.86% | 20.68% | 30.97% | 18.69% | 13.76% |
| ROE | -11.38% | -6.92% | 39.53% | 41.92% | 32.49% | 20.67% | 31.06% | 19.45% | 14.49% |
| ROA | 0.00% | 3.31% | 27.10% | 31.71% | 27.09% | 19.00% | 27.48% | 16.12% | 12.10% |
| NM % | 16.47% | 7.17% | 28.43% | 27.55% | 33.66% | 39.29% | 64.18% | 41.34% | 32.28% |
| FCF / R% | 0.00% | 0.85% | 32.61% | 4.07% | 28.61% | 22.52% | -14.28% | -15.50% | 26.42% |
| FCF / NI% | 29.35% | 11.83% | 114.73% | 14.78% | 85.01% | 57.32% | -22.26% | -37.49% | 81.83% |
| Operating Margin (OM) | 0.00 | -1.14 | -0.12 | 0.13 | 0.44 | 0.62 | 1.06 | 1.25 | 1.43 |
Per Share
| Year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|
| EPS | 0.09 | 0.05 | 0.55 | 1.54 | 1.38 | 3.02 | 6.15 | 4.47 | 3.81 |
| SPS | 0.53 | 0.69 | 1.94 | 5.58 | 4.11 | 7.69 | 9.58 | 10.80 | 11.79 |
| OCPS | 0.05 | 0.02 | 0.67 | 0.57 | 1.35 | 2.74 | 0.97 | 1.46 | 4.29 |
| FCPS | 0.03 | 0.01 | 0.63 | 0.23 | 1.18 | 1.73 | -1.37 | -1.67 | 3.12 |
| BVPS | -0.76 | -0.71 | 1.40 | 3.67 | 4.26 | 14.63 | 19.78 | 22.96 | 26.27 |
Per Share - CAGR
| Year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|
| CAGR-EPS | 0.09 | 0.05 | 0.55 | 1.54 | 1.38 | 3.02 | 6.15 | 4.47 | 3.81 |
| CAGR-SPS | 0.53 | 0.69 | 1.94 | 5.58 | 4.11 | 7.69 | 9.58 | 10.80 | 11.79 |
| CAGR-OCPS | 0.05 | 0.02 | 0.67 | 0.57 | 1.35 | 2.74 | 0.97 | 1.46 | 4.29 |
| CAGR-FCPS | 0.03 | 0.01 | 0.63 | 0.23 | 1.18 | 1.73 | -1.37 | -1.67 | 3.12 |
| CAGR-BVPS | -0.76 | -0.71 | 1.40 | 3.67 | 4.26 | 14.63 | 19.78 | 22.96 | 26.27 |